Universal infant nirsevimab prophylaxis significantly reduced RSV-related hospitalisations and outpatient visits across two seasons in Spain.

Cases of respiratory syncytial virus are increasing, but vaccines and antibody shots can keep young children out of the ...

As colder weather sets in, pediatric hospitals are seeing an increase in infants and young children diagnosed with respiratory syncytial virus (RSV) infections. RSV can lead to severe respiratory ...

CXCL12 and CXCL13 are potential biomarkers for RSV bronchiolitis severity and recurrence risk, with elevated levels indicating severe cases and recurrent wheezing, respectively. RSV remains a major ...

Respiratory viruses, including RSV, but are more typically active from October through March, according to state health ...

Giving the long-acting monoclonal antibody nirsevimab to most infants sharply reduced hospitalizations and clinic visits ...

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. While pregnant with her third child ...

Respiratory virus season is in full swing across California, with several illnesses spreading across the state. Cases of ...

NEW YORK CITY -- In September, an 8-month-old baby came into Dr. Juanita Mora's office in Chicago with an infection the doctor hadn't expected to see for another two months: RSV. Like her peers across ...

WASHINGTON -- The U.S. Food and Drug Administration has approved the first maternal vaccine intended to help protect newborns against respiratory syncytial virus (RSV). The vaccine would be given ...

In 2024, the number of cases in North Carolina was ranked "high" by the CDC. How are we faring in 2025?

Coughing, sneezing and a runny nose: You might think it is yet another cold, but if your baby is under 2 years old, it could very well be respiratory syncytial virus (RSV). RSV is a virus infecting ...